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Abstract
Colorectal cancer (CRC) is a significant cause of mortality and morbidity in the United States, 
much of which could be prevented through adequate screening. Consensus guidelines recommend 
that high-risk groups initiate screening earlier with colonoscopy and more frequently than average 
risk persons. However, a large proportion of high risk individuals do not receive regular 
colonoscopic screening. The Family Health Promotion Project (FHPP) is a randomized-controlled 
trial to test the effectiveness of a telephone-based counseling intervention to increase adherence to 
risk-appropriate colonoscopy screening in high risk individuals. Unaffected members of CRC 
families from two national cancer family registries were enrolled (n=632) and randomized to 
receive either a single session telephone counseling intervention using Motivational Interviewing 
techniques or a minimal mail-out intervention. The primary endpoint, rate of colonoscopy 
screening, was assessed at 6, 12 and 24 months post-enrollment. In this paper, we describe the 
research design and telephone counseling intervention of the FHPP trial, and report baseline data 
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obtained from the two high risk cohorts recruited into this trial. Results obtained at baseline 
confirm the need for interventions to promote colonoscopy screening among these high risk 
individuals, as well as highlighting several key opportunities for intervention, including increasing 
knowledge about risk-appropriate screening guidelines, and providing both tailored risk 
information and barriers counseling.
Keywords
colonoscopy; high risk; intervention; randomized trial
1. Introduction
Colorectal cancer (CRC) is the third most common cancer and third leading cause of cancer 
death in the United States [1] Much of the morbidity and mortality from CRC can be 
prevented through effective screening. Earlier stage diagnosis of CRC through regular 
screening could lead to survival rates of up to 90% for CRC and 80% for rectal cancer; a 
strong rationale for efforts to promote screening among average risk individuals over age 50 
[1–2] Additionally, removal of colon polyps by colonoscopy can substantially decrease CRC 
incidence.3 The small but steady decline in CRC incidence and mortality over recent 
decades has been largely attributed to increasing rates of CRC screening [3]
Having a family history of CRC is one of the strongest risk factors for CRC and provides a 
salient cue for screening. First-degree relatives of CRC patients have a two- to four-fold 
increased risk for CRC when compared to the general population. Moreover, having a single 
relative diagnosed with CRC under age 50 or two or more relatives with CRC increases risk 
three- to six-fold [4–5] Members of families with Lynch Syndrome, a rare hereditary 
syndrome also known as hereditary non-polyposis colorectal cancer (HNPCC) have an even 
higher lifetime risk of CRC approaching 80% [6–7] Greater risk based on family history has 
led to recommendations to screen these groups earlier and more frequently than average risk 
persons and to use colonoscopy as the preferred screening modality [8]
Available data indicate that colonoscopy screening is effective in individuals with Lynch 
Syndrome; screened individuals have markedly lower CRC incidence and mortality than 
those who do not receive regular screening [9–10] Moreover, at least one observational 
study reported a significant reduction in the progression from adenomas to CRC among 
family members of CRC patients screened with colonoscopy [11] Despite the evidence that 
a family history confers significant risk for CRC and that screening is effective in these 
groups, a large proportion (27–46%) of individuals with familial risk, including those with 
known or suspected gene mutations, do not receive regular colonoscopy [12–15] The 
relatively few studies that have examined predictors of adherence to CRC screening among 
individuals with familial risk suggest that socio-demographic factors, degree of family 
history, lack of regular provider or provider recommendation, perceived barriers, risk 
perception, and lack of belief that screening is effective significantly predict adherence [16–
20] Few prospective studies have assessed how modifying these factors may impact 
adherence in high risk groups [12–13,16]
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The Family Health Promotion Project (FHPP) is a randomized-controlled trial designed to 
test the effectiveness of a telephone counseling intervention to increase adherence to risk-
appropriate colonoscopy screening in members of high risk families FHPP used an 
innovative approach, tapping into two national family cancer registries, and novel methods 
including Motivational Interviewing techniques, to address this important public health 
issue. We describe here the design of the FHPP trial, the counseling intervention used as 
well as the baseline characteristics of the study population, including their knowledge, 
attitudes, beliefs, risk perceptions and self-reported barriers to CRC screening.
2. Methods
Overview of Study Design
Figure 1 provides an overview of the FHPP trial. Enrolled participants were unaffected at-
risk members of families that met criteria for either HNPCC or non-HPNCC high risk (HR) 
families that were due for colonoscopy screening within the 2-year study period. High risk 
participants were recruited from two national cancer registries; the Colorectal Family 
Registry (CFR) and the Cancer Genetics Network (CGN) [21–22] Upon providing consent 
and completion of a baseline questionnaire, participants were randomized using a block 
design by risk level (HNPCC vs. high risk), gender and family unit to the intensive or 
minimal intervention group. The minimal intervention group received a mailed packet that 
contained general health information and encouraged participants to talk with their doctor 
about appropriate CRC screening. The intensive intervention group received a single 
education and counseling session via telephone that utilized motivational interviewing (MI) 
techniques [23–24] The intervention was tailored to the participant’s age, gender, risk level 
and self reported barriers to CRC screening as reported on the baseline survey. The primary 
endpoint of the trial was colonoscopy screening within 24 months following the 
intervention, validated by endoscopy report. Assessment of CRC screening, knowledge of 
screening recommendations, attitudes and beliefs about screening and perceived CRC risk 
occurred by self-administered questionnaires at baseline and at 6, 12 and 24 month’s follow-
up. This study was approved by the Colorado Multiple Institutional Review Board (Protocol 
#03-858).
Study Population
Participants were recruited from 8 CFR and 4 CGN registry sites. These registries were 
established by the National Cancer Institute in 1997–1998 as resources to support studies on 
the etiology, prevention and clinical management of cancer with a particular emphasis on 
the genetic basis of cancer susceptibility [21–22] The CFR and CGN registries recruited 
individuals diagnosed with CRC (i.e. probands) between 1997 and 2001. With the exception 
of the Cleveland Clinic that enrolled patients from their high risk clinic, all other CFR and 
CGN registry sites participating in FHPP recruited CRC cases from population-based state 
cancer registries. Once enrolled in these registries, the proband was asked for permission to 
invite one or more of their first-degree relatives to also enroll in the registry. As part of their 
consent to enroll, all participants agreed to be contacted about future studies for which they 
might be eligible. Unaffected family members enrolled in CFR and CGN were targeted for 
recruitment for FHPP.
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Eligibility—Individuals were eligible for FHPP if they had no personal history of CRC, 
were at least 21 years of age, were English speaking and were members of a family that met 
clinical criteria for being at high risk for CRC. The definition of high risk families was 
guided by those used to stratify CRC screening recommendations [3] and was separated into 
two high risk groups. Participants were classified as HNPCC if their families met the 
Amsterdam II criteria: 3 biological relatives with CRC (or other HNPCC-related cancers: 
endometrial, small bowel, ureter or renal pelvis) with one being a first degree relative of the 
other two, at least 2 generations affected, and 1 cancer diagnosis under 50 years of age [25] 
Participants were classified as non-HNPCC, high risk (HR) if their families did not meet the 
Amsterdam II criteria but they had at least one first-degree relative diagnosed with CRC 
under age 60 or two or more first-degree relatives with CRC diagnosed at any age. HNPCC 
and HR families within the registries were identified on the basis of the validated diagnosis 
of CRC in the proband from the state cancer registry and self-reported family history 
information provided by the proband upon enrollment into the CFR and CGN. This 
information was confirmed with participants upon enrollment into FHPP.
Eligible participants must also have been due for screening colonoscopy during the 24-
month study period. Given that the recommendation for HNPCC family members is to have 
colonoscopy screening every 1–2 years, no HNPCC participants were excluded based on 
this criteria (i.e., all of these participants would be due for colonoscopy within the two year 
follow-up period). HR participants who had undergone colonoscopy within 3 years prior to 
enrollment were excluded from enrollment into FHPP as these participants would not be due 
for screening during the 2-year study period (i.e., screening recommendation for HR 
participants is colonoscopy no less than every 5 years).
Recruitment—Lists of registrants meeting inclusion criteria for FHPP were identified by 
the data coordinating centers for CFR and CGN and sent to the respective sites who 
contacted their local participants to obtain their permission to be contacted by study staff at 
the University of Colorado Cancer Center (UCCC). Once consent for contact was obtained, 
the local sites uploaded the participant’s contact information into a centralized database 
housed at Massachusetts General Hospital, the data coordinating center for the CGN and for 
FHPP. UCCC staff then approached potential participants to invite them to participate and 
obtain written consent. In some families, more than one first-degree relative was identified 
as potentially eligible and consented. Recruitment was conducted from September 2004 to 
May 2006.
Telephone Counseling Intervention
Consenting participants were randomized to the minimal intervention or telephone 
counseling groups. The counseling intervention was grounded in several complementary 
theoretical models to promote health behavior change, including the Health Belief Model 
[26–27], the Theory of Planned Behavior [28–30], and the Transtheoretical Model [31–33] 
Motivational Interviewing (MI) served as the counseling framework. The main premise of 
MI is to facilitate behavior change by helping people to explore and resolve their 
ambivalence [34–35] MI is thought to elicit the motivation required to move individuals 
through the different stages of change, and is particularly effective with individuals at early 
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stages of readiness [36] Brief forms of MI have been used successfully in health behavior 
interventions [37–38] Brief MI consists of a set or menu of techniques which follow the 
spirit and practice of motivational interviewing but do not necessarily demand a command 
of the overall method or understanding of underlying theory to be effective [37], although 
clinical skillfulness is certainly deepened through more advanced training and practice. 
Classic exemplars of brief MI techniques include readiness rulers and decisional balance 
sheets [35] These techniques were standardized in the FHPP intervention and applied after 
stages of readiness assessment. In Brief MI, the non-judgmental reflective responses and 
well-timed summaries serve to mirror and reinforce the pros/benefits of behavior change and 
the client’s self-efficacy to do so. The discussion of the barriers to change is contained, 
specific and solutions focused. Although there is an emerging literature on the efficacy of 
Brief MI in managing and modifying chronic behaviors, the FHPP study is one of a few 
published studies to focus specifically on cancer screening [39–40]
Four interviewers were trained to deliver the FHPP brief MI intervention. None had 
previous training or experience in Brief MI techniques. Interviewer training began with an 
overview of the project, followed by a specific training for the single counseling call. 
Throughout the study, supervisory staff frequently monitored live calls and provided real-
time feedback for quality control and improvement.
The telephone counseling session was conducted using computer-assisted telephone 
interviewing (CATI) software, which allowed the interviewer to receive pop-up screens 
appropriate to the participant’s level of risk, recommended screening interval based on risk 
and response to stage of change questions for colonoscopy screening and family advocacy. 
Based upon the participants response to the readiness question, the CATI provided one of 
three behavioral counseling tracks: Track 1 for those were not ready to be screened (focused 
on the cons of getting a colonoscopy and solutions for obstacles to screening); Track 2 for 
those who were ambivalent about screening (focused equally on pros and cons, using 
conversational interviewer probes designed to differentially tip the scale toward pros); and 
Track 3 for those who were ready to be screened (strongly reinforced pros). A schema of the 
full telephone counseling protocol can be found in Figure 2.
Survey Assessments
All participants were asked to complete mailed surveys at baseline and at 6, 12 and 24 
months post randomization. In addition to collecting information on colonoscopy screening 
history (had recent screening, yes/no; date of most recent test; reason for having test and 
intentions to screen), the surveys assessed several key constructs that were targeted in the 
counseling intervention, including knowledge of risk-appropriate CRC screening guidelines, 
attitudes and beliefs regarding colonoscopy (perceived efficacy and need for colonoscopy), 
self-reported barriers to CRC screening, perceived risk of CRC, and awareness and uptake 
of genetic counseling and testing. Specific questions included the survey assessments were 
adopted from similar assessments tested and utilized in a previous randomized trial to 
promote screening among first-degree relatives of breast and colorectal cancer survivors 
[41]. CRC screening history reported at baseline was based on self-report. Self-reported 
CRC screening has an overall high level of concordance (with medical record data) in 
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studies conducted in primary care settings [42,43] and individuals with a family history of 
CRC have an even higher concordance than that of individuals without a family history [43]. 
Moreover, telephone and self-administered surveys have been found to be more accurate 
then face-to-face interviews for endoscopic cancer screening behavior [44]. The baseline 
survey also captured socio-demographic information such as gender, age, race/ethnicity 
education, income, health insurance and access to a regular doctor or clinic (see baseline 
questionnaire in supplemental data for details of all questions). A description of the survey 
components is provided below.
Knowledge of risk-appropriate CRC guidelines—This section elicited subjects’ 
knowledge of CRC screening guidelines by asking ‘how often do you think you should be 
screened?’ and ‘at what age do you think a person with a family history like yours should 
start being screened?’ The colonoscopy-specific questions were imbedded in similar 
questions for other cancer screening tests such as mammography, PSA testing and skin 
exams so as to minimize the reactivity of the assessments to affect study outcomes. For 
colonoscopy, responses consistent with current screening guidelines were ‘every 1–2 years’ 
for HNPCC and no less than every 5 years for HR.
Attitudes, Beliefs and Barriers—To assess attitudes and beliefs about CRC screening, 
participants were asked how effective they thought screening tests were in detecting cancer 
and were asked whether several statements about CRC screening specifically were 
applicable to them (response options: agree/disagree/undecided). Examples of two such 
statements were, “If I eat a healthy diet, I don’t need to be screened”, and “I won’t have 
screening unless I have bowel or abdominal symptoms” (see supplemental data for entire 
baseline questionnaire). Similarly, seventeen potential barriers or reasons for not having 
CRC screening including being “too young”, “ too busy”, and “disgusted by the tests”, were 
given and participants were asked to report whether any of these barriers were reasons for 
them not be screened (yes/no/unsure). The complete list of measures is presented in Tables 2 
and 3.
Perceived risk and knowledge of familial CRC risk—Participants were asked what 
they thought their risk of CRC was compared to others their age that do not have close 
relatives with CRC (response choices: much higher, a little higher, the same, a little lower, 
much lower, don’t know). Participants were also asked how concerned they were about 
getting CRC (very, moderately, not very or not at all, don’t know) and how the diagnosis of 
CRC in their family made them feel about their own chances of getting CRC (chances were 
a lot more, a little more, didn’t change chances, less, don’t know). In addition, several 
questions were asked to elicit participants’ perception about the role of family history and 
genetics in causing CRC and about their knowledge of and experience with genetic 
counseling and testing for genetic predisposition to CRC.
All assessments were completed by mail and then scanned for upload into the project 
database that was designed and maintained by the data coordinating center at Massachusetts 
General Hospital.
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The primary objective of FHPP is to test the effectiveness of a telephone-based, counseling 
intervention as compared to a mailed packet containing general health information to 
increase adherence to colonoscopy screening in high risk individuals. The main hypothesis 
of greater adherence in the counseling intervention group will be tested using survival 
analysis techniques so as to account for variations in follow-up time. Trial successes will 
include participants who had a colonoscopy during the 24-month study confirmed by 
endoscopy report and trial failures will be participants who did not have colonoscopy. 
Participants will be censored at the time of colonoscopy or last completed follow-up. Cox-
proportional hazards models will be used to assess the intervention effect while adjusting for 
potential confounders and other explanatory variables such as age, gender, risk level and 
insurance status. A conservative sample size of 240 in each intervention arm was selected to 
account for drop-outs and familial clustering and to achieve at least 80% power to detect a 
15% difference in screening adherence between intervention groups.
Secondary analyses will seek to identify mediating factors as defined by four criteria 
developed by Baron & Kenny (1986) and Holmbeck (1997) [45–46]; (i) the counseling 
intervention when compared to the control condition should increase screening adherence in 
the study population at 24 months follow-up, (ii) the intervention significantly modulates the 
hypothesized mediating variables at 6 and 12 months in a positive direction, (iii) the 
mediating variables at 6 and 12 months are predictive of screening adherence in the study 
population at 24 months follow-up, and (iv) controlling for mediating variables at 6 and 12 
months substantially reduces or eliminates the intervention effects observed on screening 
adherence at 24 months follow-up. As noted previously, potential mediating factors include 
knowledge of risk-appropriate CRC screening guidelines, attitudes, beliefs and reported 
barriers to screening and perceived risk related to CRC in the family. These analyses will 
utilize general estimating equations (GEE) within logistic regression. In defining a candidate 
set of mediating variables by criterion (iv) above, stepwise procedures will be used for 
model selection using the variables that are significant by univariate analysis.
Results
A total of 1068 participants were identified by participating CFR and CGN sites as 
potentially eligible for FHPP and contacted for enrollment. Of these, 156 were found to be 
ineligible; of the remaining 912, 632 consented and 280 refused (or did not respond) for a 
participation rate of 69 percent. There were no significant differences between responders 
(n=632) and non-responders (n=280) with respect to gender, age, race/ethnicity or risk level 
(data not shown). Among the 156 individuals deemed ineligible, 75 were due to the 
individual not being due for their next colonoscopy within the 2 year study period (as 
described above, this exclusion criteria was applicable to HR participants), 49 did not 
confirm a family history at baseline that was consistent with the high-risk history previously 
reported by the affected family member initially enrolled in the registry (the proband), 9 had 
a recent CRC diagnosis and 7 reported they had tested negative for the HNPCC genes 
(indicating lower risk). The most common reasons were refusal were ‘not interested’ (53%) 
or ‘too busy’ (25%). There were no significant differences between potential participants 
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who refused and those who consented to participate with respect to gender, age, race/
ethnicity or risk level.
Characteristics of enrolled study participants, overall and according to risk level, are 
presented in Table 1. Approximately 60% of the participants were women. Participants were 
predominately middle-aged and older (70% were 50 years or older), educated (78% above 
high school), Caucasian (93%), and reported having health insurance and a regular doctor 
(92%). Sixty-one percent of participants reported incomes at or above $45,000 per year. 
Twenty-six percent of participants met criteria for HNPPC (n=165), 74% for HR (n=467). 
There were no differences in demographic factors by risk level. The 632 participants 
enrolled represented 541 families; 468 families (87%) had one member enrolled, 60 families 
(11%) had two members enrolled and the remaining 13 families (2%) had three or more 
members enrolled.
Data from select baseline measures are presented in Tables 2–5. Data are presented for the 
overall study population and according to risk level as several measures including what 
denotes accurate knowledge of risk-appropriate screening recommendations, will differ 
between these two risk groups. Overall, seventy five percent of participants reported ever 
having a colonoscopy (Table 2). The proportion of those who ever had a colonoscopy was 
higher in HNPCC participants (95%) than in the high-risk group (69%). Fifty-six percent of 
HNPCC participants were adherent with colonoscopy screening guidelines at baseline as 
they reported having had colonoscopy within 2 years of enrollment. Because we excluded 
HR participants that had colonoscopy within 3 years of enrollment, we cannot estimate 
overall baseline adherence in the HR group. However, within our sample of 467 HR 
participants who were due for colonoscopy, the majority (55%), had either had their last 
colonoscopy more than 5 years or prior had never had a colonoscopy. When asked when 
they planned to have colonoscopy, only a little over half of the participants said that they 
planned on having a colonoscopy with the next 1–2 years though based on eligibility criteria 
for the study, all would be due for their next screening within this time frame. There was 
considerable variability among participants as to how often they thought they should be 
screened. Only 22% of the HNPCC group thought they should be screened every 1–2 years 
which is the current recommendation for these individuals. Among the HR group, 52% of 
participants thought they should be screened with colonoscopy every 3–5 years (which is 
consistent with the current recommendation for this group to be screened no less frequently 
than every 5 years), 29% thought they that should be screened at intervals longer than 5 
years and 9% were unsure how often they should have colonoscopy. Knowledge of 
guidelines appeared to correlate with intentions to screen. Among participants who were 
aware of the current guidelines in the HNPCC group, 83% reported intention to screen 
within 1–2 years, compared to 46% who were not aware of the current guidelines. The 
corresponding figures for the HR group were 61% and 35%, respectively (data not shown).
Attitudes and beliefs about CRC screening
Participants decidedly agreed (90%) that colonoscopy was effective at detecting CRC (data 
not shown). As indicated in Table 3, the majority (>90%) endorsed statements affirming the 
benefits of colon screening as part of good general health care, and disagreed (>90%) with 
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statements that refuted the need for screening due to such factors as age, having a healthy 
diet, or a history of negative screening exams. The only statement that resulted in any 
disparate response between risk groups pertained to symptoms, “I won’t have screening 
unless I have bowel or abdominal symptoms.” Overall, about 16% of all participants agreed 
with this statement and HR participants were more likely than HNPCC participants to agree 
(18% vs. 8%).
Barriers to CRC screening
Self-reported barriers to CRC screening are shown in Table 4. About 70% of participants 
reported at least one barrier to screening. The median number of barriers reported was two 
(range=0 to 14). The most commonly cited barriers were anxiety over results (20%), cost 
(22%), lack of symptoms (34%), fear of pain (21%), busy schedule (26%), worry about test 
preparation (25%), fear of the test (23%), and lack of a physician recommendation (16%). 
Seventy-two percent of the HR participants and 54% of the HNPCC participants reported 
one or more barrier to CRC screening. HR participants were more likely than HNPCC 
participants to report lack of a physician referral, cost, fear, pain, lack of symptoms, and 
being too busy as important barriers to screening.
Perceived risk of CRC and knowledge of familial risk
Over 80% of participants believed that their risk of developing CRC was ‘a little’ or ‘much 
higher’ than people the same age without similar family history of CRC (Table 5). Nearly 
70% of the HNPCC group felt their risk was ‘much higher’ than others (only 35% in HR). 
The majority of participants also indicated they were moderately or very concerned about 
getting CRC (70%) and felt their own chances of getting CRC were greater given the 
diagnosis of CRC in a family member (87%). A substantial proportion of participants (34% 
of HNPCC and 16% of HR) were very concerned about getting CRC and felt that their 
chances of getting CRC were a lot more given the diagnosis of CRC in their family (73% 
and 39%).
When asked how important genetics and/or family history of CRC is in causing CRC, over 
half (53%) of participants thought it was ‘very’ important and another 40% thought it was 
somewhat important (data not shown). Only 40% of participants had ever heard of genetic 
testing for CRC (63% HNPCC; 32% HR; p<0.05);14% had been advised to have testing and 
3% reported having had genetic testing.
Discussion
Previous research, largely in average risk individuals, has shown that various attitudes, 
beliefs, risk perceptions, and self-reported barriers predict adherence to CRC screening, 
reflecting key theory-based constructs or targets for educational interventions [16,47–51] 
Relatively few studies have examined the frequency of these factors and how they relate to 
screening adherence among individuals at increased risk for CRC due to family history [16–
20] Moreover, very few prospective studies have assessed how modifying these factors, for 
example knowledge of genetic risk, may affect screening adherence in these high risk 
groups [12–13,16] The FHPP is a novel prospective trial designed to test the effectiveness of 
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a telephone counseling intervention to promote colonoscopy screening among two high risk 
cohorts: HNPCC and non-HNPCC high risk (HR) family members. Using Motivational 
Interviewing techniques, the single-session counseling intervention incorporates educational 
messages about familial risk and appropriate screening intervals and mitigates barriers to 
screening in order to increase colonoscopy adherence. Information from the baseline 
assessment reported here, is used to tailor the intervention to individual participants.
Data from the baseline survey revealed surprisingly low colonoscopy screening rates in 
these high-risk groups. Despite their high risk profile, and despite the fact that all 
participants were members in one of two high risk registries, nearly a third of the HR group 
did not report a prior colonoscopy (5% in the HNPCC group), and baseline adherence to 
current CRC screening guidelines for the HNPCC group was only 56% (we could not 
estimate baseline adherence among the HR risk due to exclusion of participants that had 
colonoscopy within the previous 3 years). Also alarming was that only 50% of participants 
(HNPCC = 55%, HR = 50%) expressed intention to have colonoscopy in the next 1–2 years, 
though all were due for colonoscopy during this time frame.
These low rates of colonoscopy screening and intentions to screen within the recommended 
interval underscore a significant public health challenge, particularly since colonoscopy 
screening offers both primary and secondary prevention opportunities for reducing CRC 
burden. These findings also raise the key question of how much these high rates of non-
adherence and low intentions to screen could be improved through educational interventions 
and outreach. Importantly, results from these analyses can help inform efforts to meet this 
critical challenge. For example, these results indicate that both risk groups had strongly 
positive attitudes toward CRC screening and were aware of the efficacy of colonoscopy 
screening, suggesting that screening efficacy messages may be less effective as a central 
theme in educational interventions to promote colonoscopy in these groups. The same 
conclusion can be inferred for various attitudes and beliefs regarding the need for CRC 
screening. For example, attitudes and beliefs that might minimize the perceived need for 
screening were almost universally rejected in both high risk groups (e.g., eating a healthy 
diet, having a rectal exam, screening not useful, diagnosis would occur too late, etc.).
Based on this study, risk perceptions regarding CRC and tailored barriers counseling would 
seem to offer more opportunities for intervention. A substantial percentage of participants in 
both risk groups (20–30%) were unaware of their elevated risk status suggesting the value of 
tailored risk messages to correct this misinformation. Even more opportunities to promote 
CRC screening in these groups may exist for tailored barriers counseling. About 55% of the 
HNPCC group reported at least one barrier to screening, compared to 70% of the HR group. 
Underscoring the need for tailored barriers counseling is the fact that no single barrier was 
dominant for either group, although a core set of barriers did emerge. These included no 
symptoms, preparation for endoscopy, fear and anxiety about the test and test results, cost, 
no doctor recommendation, and convenience factors, all of which have been reported 
previously [16,47–51] The overall prevalence of barriers was higher within the HR group 
and several specific barriers were also more prevalent including: having no symptoms (40% 
vs. 19%) and no doctor recommendation (20% vs. 7%). The fact that the HNPCC group 
reported fewer barriers and lower frequency of all specific barriers may reflect that this 
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group had more experience with colonoscopy, is better educated about screening because of 
their stronger family history, and/or that barriers might seem less important in light of their 
increased risk. It is also plausible that by virtue of their exceptionally high risk status, health 
care providers may be more likely to stress the importance of CRC screening and to make 
referrals for screening to HNPCC family members.
While risk perception and barrier messages would appear to offer important opportunities 
for intervention, perhaps the single greatest opportunity to promote adherence to CRC may 
also be the easiest to remedy. Nearly 80% of the HNPCC group was not aware that they 
should be screened every 1–2 years, and 40% of the HR group was not aware that they 
should be screened no less than every 5 years. Our data also suggest that low intentions to 
screen according to current guidelines may be a function of not knowing what is 
recommended. For both risk groups, the percentage of participants who planned to undergo 
screening within 2 years was nearly double among those who were aware of the 
recommended guidelines.
Taken together, these findings suggest several key considerations for designing health 
education programs to promote colonoscopy screening among high risk groups. First, in 
light of the positive attitudes and beliefs about colonoscopy screening but the low level of 
intentions to get screened within recommended guidelines it would appear that one major 
goal should be to increase the rate of intentions to be screened. Second, the apparent 
widespread lack of information about current guidelines for CRC screening in these two 
high risk groups, suggests that providing this information could in itself serve as a catalyst to 
be screened. Tailored risk messages might also serve this same function, since about 
20%-30% of these high risk individuals were unaware of their elevated risk status. Third, 
our data suggest that the optimal intervention would be one that also facilitates movement 
from intentions to action by addressing barriers to screening, where such efforts can 
anticipate a core set of barriers as described above. Thus, we conclude that the optimal 
intervention would seem to be one that must remain flexible and individualized, that 
attempts to identify knowledge gaps and to resolve ambivalence regarding intentions (if 
needed), and that then strategically helps in the transition from intentions to action. 
Importantly, this is precisely the type of intervention being tested in FHPP using a 
telephone-based MI intervention, the results of which will be forthcoming.
This study has several important strengths. Namely, the FHPP is one of very few 
prospective intervention trials designed to promote colonoscopy screening in members of 
high risk families. Moreover, the baseline assessment represents a large, population-based 
sample of high risk individuals that collected more detailed information ever reported for 
these high risk groups. Several important limitations of this study should also be noted. Both 
high risk groups were predominately Caucasian, highly educated, had health insurance and a 
regular source of health care and thus might not accurately represent lower socioeconomic 
or minority populations. Moreover, because we excluded HR participants that had had 
colonoscopy in the previous 3 years, participants in our HR group may not fully represent 
the distribution of attitudes and behaviors of HR individuals in the general population who 
are adherent with CRC screening. Another study limitation is that the sample consisted of 
self-selected participants in two high risk cancer registries. It is likely that their interest in 
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joining these registries signals increased awareness and concern for their familial risk, which 
may not generalize to other comparable high risk groups in the community. Although the 
registries have not systematically disseminated information about colonoscopy to their 
participants, they send out annual newsletters and serve as an educational resource for those 
participants who request information. Thus, by virtue of their participation in these 
registries, our participants may be more motivated and educated about screening than would 
high risk individuals in the general population.
Finally, while these study limitations should be acknowledged, it is also important to note 
that these limitations are likely to yield results that underestimate the challenge of promoting 
CRC screening among high risk groups in general, including similar populations who are 
not enrolled in high risk registries and those who are likely to be more underserved based on 
income, education and race/ethnicity. For these populations, their knowledge, attitudes, 
beliefs, risk perceptions and behavioral intentions to be screened may be less supportive of 
CRC screening than the results of this study would indicate, and their rates of non-adherence 
to CRC screening guidelines may actually be greater than suggested in this study. 
Accordingly, while the results obtained from this study underscore the need to continue 
developing and testing interventions to promote CRC screening among high risk individuals, 
this need may be even more compelling than indicated by this analysis.
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Table 1









 Male 261 (41) 81 (49) 180 (39)
 Female 371 (59) 84 (51) 287 (61)
Age
 < 40 36 (1) 12 (7) 24 (5)
 40 – 49 152 (24) 33 (20) 119 (25)
 50 – 64 272 (43) 83 (50) 189 (40)
 65+ 172 (27) 37 (22) 135 (29)
Race
 African American 11 (2) 2 (1) 9 (2)
 Caucasian 589 (93) 155 (94) 434 (93)
 Other 23 (4) 5 (3) 18 (4)
 Missing 9 (1) 3 (2) 6 (1)
Ethnicity
 Hispanic 15 (2) 3 (2) 12 (3)
 Non-Hispanic 605 (96) 161 (98) 444 (95)
 Missing 12 (2) 1 (1) 11 (2)
Education
 Post college 117 (19) 29 (18) 88 (19)
 College graduate 175 (28) 49 (30) 126 (27)
 Some college/tech school 195 (31) 50 (30) 145 (31)
 High school/GED 121 (19) 30 (18) 91 (19)
 Less than high school 20 (3) 6 (4) 14 (3)
 Missing 4 (<1) 1 (1) 3 (1)
Household Income
 $70,000 or more 235 (37) 65 (39) 170 (36)
 $45,000 – $69,999 149 (24) 45 (27) 114 (24)
 $30,000 – $44,999 106 (17) 23 (14) 83 (18)
 $15,000 – $29,999 68 (11) 12 (7) 56 (12)
 < $15,000 28 (4) 7 (4) 21 (4)
Missing/Don’t know 36 (6) 13 (8) 23 (5)
Health Insurance Status
 Insured 603 (95) 158 (96) 445 (95)
 Not insured 25 (4) 6 (4) 19 (4)






























 Missing 4 (<1) 1 (1) 3 (1)
Have regular doctor or clinic
 Yes 582 (92) 152 (92) 430 (92)
 No 48 (8) 13 (8) 35 (7)
 Missing 2 (<1) 0 2 (<1)
†
HNPCC = hereditary non-polyposis colon cancer
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Table 2
Baseline data: Colonoscopy screening history, intentions to screen and knowledge about frequency of 
screening








 Yes 477 (75%) 157 (95%) 320 (69%)
 No 155 (25%) 8 (5%) 147 (31%)
When was your last colonoscopy?
 2 years ago or less 95 (15%) 92 (56%) 0*
 >2–5 years ago 250 (39%) 43 (26%) 207 (44%)
 More than 5 years ago 131 (21%) 21 (13%) 110 (24%)
 Never had one 155 (25%) 8 (5%) 147 (31%)
Intend to have colonoscopy in next 1–2 years?
 Yes 325 (52%) 90 (55%) 232 (50%)
 No 307 (48%) 75 (45%) 235 (50%)
How often should you have colonoscopy? Every…
 1 or 2 years 75 (12%) 36 (22%)† 39 (8%)
 >2–5 years 355 (56%) 113 (68%) 242 (52%)†
 >5–9 years 129 (20%) 11 (7%) 118 (25%)
 10+ years 20 (3%) 2 (1%) 18 (4%)
 Never 3 (<1%) 0 3 (1)
 Don’t know 42 (7%) 1 (1%) 41 (9%)
†
HNPCC = hereditary non-polyposis colon cancer
*
HR excluded from FHPP if had colonoscopy less than 3 years prior to enrollment
†
Bolded represents recommended routine screening interval for this group
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Table 3




HNPCC† (N=165) HR† (N=467)
% agree
If I eat a healthy diet, I don’t need to be screened. 4 3 4
If I have a rectal exam, I don’t need to be screened. 1 0 1
Once I have had a couple of negative tests I do not need any. 3 1 3
I won’t have screening unless I have bowel/abdominal symptoms. 16 8 18 *
Colon cancer screening is part of good overall health care. 94 95 93
People who tell me not to bother being screened are right. 0 0 0
If screening finds something, it will be too advanced to cure. 1 1 1
Colon cancer screening is not a useful test for people my age. 1 1 1
Colon cancer screening is not reliable. 1 0 1
†
HNPCC = hereditary non-polyposis colon cancer; HR = High Risk
*
p<0.05 for difference between risk groups
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Table 4




HNPCC† (165) HR† (467)
% yes % yes
I am too young or too old. 5 4 6
I feel anxious about the results. 20 19 20
The cost is too high. 22 15 24*
I don’t have a doctor. 6 5 6
The tests are embarrassing. 11 7 13
My doctor hasn’t recommended it. 16 7 20*
The tests are frightening or intimidating. 23 16 25*
I have other health problems. 13 6 16
I have no symptoms or problems. 34 19 40*
I think that the tests could be painful. 21 13 24*
I fear that I could be injured. 9 3 10
I have a busy schedule. 26 16 30*
I feel it is unnecessary. 4 2 5
I feel the FOBT is disgusting. 11 10 11
I am worried about the preparation for endoscopy 25 21 26
I don’t have insurance that covers it. 15 11 16
I feel the screening doesn’t work. 1 1 1
Total reporting any barrier N (%) 423 (67%) 89 (54%) 334 (72%)**
†
HNPCC = hereditary non-polyposis colon cancer; HR = High Risk
*
p<0.05 for difference between risk groups
**
p<0.01 for difference between risk groups
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Table 5




HNPCC† (165) High Risk (467)
N (%)
What do you think your risk of getting CRC is compared to people your age who do NOT 
have a family history?
 Much higher 275 (44) 113 (68) 162 (35) *
 A little higher 241 (38) 37 (22) 204 (44)
 The same 63 (10) 6 (4) 57 (12)
 A little or much lower 25 (4) 6 (4) 19 (4)
 Don’t know 26 (4) 3 (2) 23 (5)
How concerned are you about getting colon cancer?
 Very concerned 132 (21) 56 (34) 76 (16) *
 Moderately concerned 312 (49) 76 (46) 236 (51)
 Not very/not at all concerned 170 (27) 31 (19) 139 (30)
 Don’t know 7 (1) 1 (1) 6 (1)
How did the diagnosis of colon cancer in your family make you feel about your own 
chances of getting CRC?
 My chances were a lot more 300 (47) 120 (73) 180 (39) *
 My chances were a little more 250 (40) 40 (24) 210 (45)
 No change/chances were less 67 (11) 5 (3) 62 (13)
 Don’t know 12 (2) 0 12 (3)
†
HNPCC = hereditary non-polyposis colon cancer
*
p<0.001 for difference between risk groups
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